Globus Medical (GMED) vs Merit Medical Systems (MMSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Merit Medical Systems (MMSI) has outperformed Globus Medical (GMED) over the past year, losing 3.3% versus a loss of 22.2%. Over five years, MMSI leads with a +27.6% price change compared with +4.6% for GMED. Globus Medical is the larger company by market cap ($8.86 billion vs $5.05 billion), about 1.8 times the size.
On valuation, Globus Medical trades at a lower forward P/E (12.5x vs 18.1x for Merit Medical Systems). Globus Medical converts more of its revenue into profit, with a net margin of 18.3% versus 8.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GMED | MMSI |
|---|---|---|
| Share price | $66.89 | $84.34 |
| Market cap | $8.86B | $5.05B |
| 1-day change | -2.49% | -0.08% |
| YTD return | -23.39% | -4.31% |
| 1-year return | -22.24% | -3.28% |
| 5-year return | +4.60% | +27.58% |
| P/E ratio (TTM) | 16.48 | 31.59 |
| Forward P/E | 12.53 | 18.06 |
| EPS (TTM) | $4.06 | $2.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.94B | $1.52B |
| Revenue growth (YoY) | +16.65% | +11.75% |
| Net income (latest FY) | $537.87M | $128.49M |
| Gross margin | 67.41% | 48.70% |
| Operating margin | 16.33% | 12.19% |
| Net margin | 18.30% | 8.48% |
| 52-week high | $101.40 | $94.85 |
| 52-week low | $66.63 | $59.74 |
| Distance from 52-week high | -34.03% | -11.08% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +39.68% | +26.87% |
| Average volume | 1.63M | 656.91K |
| Shares outstanding | 110.04M | 59.92M |
| Employees | 6,000 | 7,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MMSI has outperformed GMED by 19.0 percentage points over the past year.
- Merit Medical Systems trades at a higher earnings multiple (31.6x vs 16.5x trailing P/E).
- Globus Medical is more profitable, keeping 18.3 cents of every revenue dollar as net income versus 8.5 cents for Merit Medical Systems.
About Globus Medical
GMED stock →Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 6,000 employees
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
GMED vs MMSI FAQ
Which is bigger, Globus Medical or Merit Medical Systems?
Globus Medical (GMED) is larger, with a market capitalization of $8.86B compared with $5.05B for Merit Medical Systems (MMSI).
Which stock has performed better over the past year, GMED or MMSI?
MMSI returned -3.28% over the past 12 months, compared with -22.24% for GMED (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GMED or MMSI?
GMED has the lower trailing P/E at 16.5, versus 31.6 for MMSI. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Globus Medical and Merit Medical Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.